Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class ASSE: 688505

Announcement on the Acceptance of the Drug Marketing Application for Aminolevulinic Acid Hydrochloride Powder for Oral Solution for Visualization in Glioma Surgery

· Issued by Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on the Acceptance of the Drug Marketing Application for Aminolevulinic Acid Hydrochloride Powder for Oral Solution for Visualization in Glioma Surgery

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis